首页|Antidepressant effects of Peiyuan Jieyu formula in a mouse model of chronic stress in conjunction with lipopolysaccharide-induced depression

Antidepressant effects of Peiyuan Jieyu formula in a mouse model of chronic stress in conjunction with lipopolysaccharide-induced depression

扫码查看
Objective:To explore the mechanism of the Peiyuan Jieyu formula in treating depression by assessing its impact on a lipopolysaccharide-induced(LPS-induced)depression mouse model.Methods:We created a mouse model of depression by exposing mice that had previously received chronic stress to intraperitoneal LPS injections.The mice were divided into the following groups:control,model,fluoxetine,Tiansi Yin,Sini powder,and low-,medium-,and high-dose Peiyuan Jieyu formula groups.Forced swim and tail suspension tests were used to assess the efficacy of the depression(despair)model,and weight gain rates were also measured.Furthermore,serum levels of various depression and inflammation-associated molecules,including tumor necrosis factor-α(TNF-α),interferon-γ(IFN-γ),tryptophan,5-hydroxytryptamine,kynurenine(KYN),and kynurenic acid(KA)were assessed.Further-more,the expression levels of ionic calcium-binding adaptor molecule-1(IBA-1)and indoleamine 2,3-dioxygenase(IDO)mRNA in hippocampal microglia were measured.Results:The model group displayed greater despair-associated immobility,which was shortened in response to various doses of Peiyuan Jieyu formula.Furthermore,formula administration significantly reduced serum TNF-α levels and hippocampal IDO mRNA expression.The high formula dose also reduced IFN-y and IBA-1 levels,the latter was also decreased in response to the medium formula dose.However,the low formula dose reduced serum KYN level and KYN/tryptophan(TRP)and KYN/KA ratios.Conclusion:The Peiyuan Jieyu formula holds immense potential in treating depression in a mouse model,potentially inhibiting inflammation and improving TRP-KYN metabolic disorders.

Peiyuan Jieyu formulaDepressionChronic stressLipopolysaccharideInflammationTryptophan pathway

Qin Tang、Yu Li、Tao Yang、Xiaoxu Fan、Lina Li、Hongsheng Chang

展开 >

School of Chinese Materia Medica,Beijing University of Chinese Medicine,Beijing 102488,China

Institute of Chinese Materia Medica,China Academy of Chinese Medical Sciences,Beijing 100700,China

Chinese Medicine Department,Tianjin Institute of Pharmaceutical Inspection,Tianjin 300070,China

School of Chinese Medicine,Beijing University of Chinese Medicine,Beijing 102488,China

展开 >

国家自然科学基金

81373584

2024

中医科学杂志(英文)
北京中医药大学,清华大学出版社有限公司

中医科学杂志(英文)

ISSN:2095-7548
年,卷(期):2024.11(1)
  • 43